Clinical Trial Update: An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness [Phase 1, Phase 2]

View source ↗

Summary

Open-label Phase 1/2 UCLA study evaluating mitoquinone/mitoquinol mesylate to prevent severe viral illness in adults; results were posted after completion of th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Viral Infection

Drugs mentioned

• Mitoquinone/Mitoquinol Mesylate (mitoquinone/mitoquinol mesylate)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Respiratory Viral Infection, Antiviral Treatment | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-05-10